The leucocyte nadir, a predictor of chemotherapy efficacy?
Open Access
- 9 July 1999
- journal article
- editorial
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (11), 1681
- https://doi.org/10.1038/sj.bjc.6690583
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancerEuropean Journal Of Cancer, 1998
- Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancerBritish Journal of Cancer, 1997
- Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patientsNature Medicine, 1996